

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1030 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 41.04 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 33.79 | Oscillator | Neutral |
| Williams %R (14) | -63.35 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.50 (Hist -0.05) | Oscillator | Strong Sell |
| Average Directional Index (14) | 22.21 (+DI 16.2 / -DI 27.1) | Trend |
Current price $8.18
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Sep 29, 26 |
| EMA 20 | 8.63 | MA | Strong Sell |
| SMA 20 | 8.81 | MA | Strong Sell |
| EMA 50 | 9.56 | MA | Strong Sell |
| SMA 50 | 9.52 | MA | Strong Sell |
| SMA 200 | 13.43 | MA | Strong Sell |
| HC Wainwright & Co. |
| maintain |
| Buy |
| Buy |
| Mar 10, 26 | Needham | maintain | Buy | Buy |
| Mar 9, 26 | B. Riley Securities | maintain | Buy | Buy |
| Mar 6, 26 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Mar 6, 26 | Roth Capital | maintain | Buy | Buy |
| Mar 6, 26 | Craig-Hallum | maintain | Buy | Buy |
| Nov 7, 25 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Aug 8, 25 | HC Wainwright & Co. | maintain | Buy | Buy |
| Aug 8, 25 | Cantor Fitzgerald | maintain | Overweight | Overweight |
FY2024 · 10-K disclosure
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Aug 21, 26 | Sun Kang | director | S-Sale | 62,101 @ $10.34 | $642.2K |
| Aug 21, 26 | Stefan Constantin Ionel | officer: Chief Technology Officer | S-Sale | 29,681 @ $10.34 | $306.9K |
| Aug 21, 26 | Stepien Thomas M | director, officer: Chief Executive Officer | S-Sale | 23,529 @ $10.34 | $243.3K |
| Aug 24, 26 | Stepien Thomas M | director, officer: Chief Executive Officer | S-Sale | 8,000 @ $10.03 | $80.24K |
| Aug 25, 26 | Stepien Thomas M | director, officer: Chief Executive Officer | G-Gift | 5,000 | — |
| Aug 25, 26 | Stepien Thomas M | director, officer: Chief Executive Officer | G-Gift | 5,000 | — |
| Aug 25, 26 | Stepien Thomas M | director, officer: Chief Executive Officer | G-Gift | 5,000 | — |
| Aug 25, 26 | Stepien Thomas M | director, officer: Chief Executive Officer | G-Gift | 346 | — |
Stock news · updated daily
Amprius Technologies NYSE: AMPX Q3 trend shift is shocking at face value, given the 68% correction in its share price over that period. During the quarter, shares were up as much as 3,877% from their 2024 lows, offering a compelling profit for early investors.
Agreement covers Amprius silicon-anode pouch cells from partial assembly through full cell production at CAMINUS's Indianapolis facility INDIANAPOLIS, Oct. 5, 2026 /PRNewswire/ -- CAMINUS (formerly EnPower), a U.S. manufacturer of lithium-ion battery cells and electrodes, today announced a contract manufacturing agreement with Amprius Technologies, Inc. (NYSE: AMPX), a developer and manufacturer of silicon-anode lithium-ion batteries. Under the agreement, CAMINUS will manufacture Amprius-designed pouch cells at its Indianapolis facility, adding domestic production capacity for Amprius customers in aviation, defense, and uncrewed systems.
Amprius Technologies NYSE: AMPX just received a new $75 million Department of War (DoW) grant that completely changes the narrative and strengthens the bull case. In short, the money shifts the company from a high-risk speculation with interesting technology to a primary, in-demand supplier for government needs, with an accelerated timeline to profitability.
[url="]Amprius Technologies[/url] (âAmpriusâ or the âCompanyâ) (NYSE: AMPX), a leader in high-performance batteries, has been awarded a grant of up to $
FREMONT, Calif.--(BUSINESS WIRE)--Amprius Technologies (“Amprius” or the “Company”) (NYSE: AMPX), a leader in high-performance batteries, has been awarded a grant of up to $75 million from the U.S. Department of War (“DoW”) to retrofit an existing domestic production line from EV batteries to high-energy density cells for unmanned aerial systems. The grant was awarded through the DoW's Industrial Base Analysis and Sustainment (“IBAS”) program, which funds domestic manufacturing capabilities cri.
Amprius Technologies is rapidly scaling its silicon-anode battery business, with SiCore driving 98% of Q2 revenue and strong European drone demand. AMPX achieved 126% y/y revenue growth and 1,800 bps gross margin expansion to 27%, with adjusted EBITDA nearing break-even and a robust $74.5m cash position. A key near-term growth lever is defense drone demand, especially in Europe; U.S. market entry hinges on NDAA-compliant domestic production targeted for 2027.
FREMONT, Calif.--(BUSINESS WIRE)--Amprius Technologies ("Amprius" or the "Company") (NYSE: AMPX), a leader in silicon anode lithium-ion batteries, today announced a new 500 Wh/kg SiCore® cell, designed for long-endurance aviation. The cell delivers 500 Wh/kg at a 1C continuous discharge rate and can be produced on conventional lithium-ion battery manufacturing equipment. Reaching 500 Wh/kg has typically required specialized materials handling and non-standard cell construction. Second-generatio.
FREMONT, Calif.--(BUSINESS WIRE)--Amprius Technologies, Inc. (“Amprius” or the “Company”) (NYSE: AMPX), a leader in silicon anode lithium-ion batteries, today announced its schedule for September appearances and activities.Commercial UAV Expo 2026Date: September 1-3, 2026Location: Caesars Forum; Las Vegas, NVEvent Details: Amprius will exhibit at booth 1635. Members of the Amprius Business Development team are available for one-on-one meetings. If you are interested in scheduling a meeting with.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | -0.02 | -0.03 | Miss -25.0% | $34.03M |
| May 6, 2026 | -0.02 | -0.04 | Miss -100.0% | $28.54M |
| Mar 4, 2026 | -0.04 | -0.01 | Beat 73.7% | $25.23M |
| Nov 6, 2025 | -0.06 | -0.03 | Beat 50.0% | $21.43M |
| Aug 7, 2025 | -0.08 | -0.05 | Beat 37.5% | $15.07M |
| May 8, 2025 | -0.09 | -0.08 | Beat 11.1% | $11.28M |
TTM vs. 5-year historical average (annual ratios)
| Metric | AMPX | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -28.1x | -33.1x · sector 18.4x | Discount |
| Forward P/E (FY26E) | -102.3x | EPS est. -0.08 | Elevated |
| Price / Book | 9.3x | 18.2x | Discount |
| Price / Sales | 10.9x | 106.3x | Discount |
| EV / EBITDA | -32.3x | -35.8x | In line |
| Return on equity | -34.8% | — | Weak |
| Gross margin | 22.3% | -102.8% | Below hist. |
| Debt / Equity | 0.05 | 0.31 | Conservative |
| Piotroski / Altman Z | 3/9 | Z 29.11 | Safe zone |
Discounted cash flow model
| 4 | Aug 25, 2026 | 2026-08-25 17:21:20 | View |
| 8-K | Aug 13, 2026 | 2026-08-13 16:49:44 | View |
| SC 13G/A | Aug 10, 2026 | 2026-08-10 16:13:21 | View |
| 10-Q | Aug 6, 2026 | 2026-08-06 16:22:44 | View |
| 8-K | Aug 4, 2026 | 2026-08-04 16:15:13 | View |
| SC 13G/A | Jul 27, 2026 | 2026-07-27 16:25:22 | View |
Proxy statement (DEF 14A) disclosures